Home > PS Ratio > VIMTA LABS

VIMTA LABS
PS (Price/Sales) Ratio

The Current P/S Ratio of VIMTA LABS is 5.03.

Share Price ₹743.3Nov 19,2024
Market Cap ₹1,650.0 Cr
Sales-TTM₹327.9 CrTTM-Consolidated Results
Price/Sales5.03xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for VIMTA LABS
Please provide your vote to see the results
VIMTA LABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of VIMTA LABS is calculated as :

Current Market Cap [ ₹1,650.0 Cr] as on Nov 19,2024

(/) Sales [ ₹327.9 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.03x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for VIMTA LABS , the investors are currently willing to pay '5.03 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !

The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.

Historical PS (Price/Sales) ratio chart of VIMTA LABS


PS Ratio Performance Analysis for VIMTA LABS

- VIMTA LABS 's latest p/e ratio is 5.03x.

- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.

- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.

- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.


How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
VIMTA LABS 327.95.031,650.0
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.47425,930.0
CIPLA LTD26,512.04.48118,828.0
DR REDDYS LABORATORIES LTD30,084.93.37101,290.0
ZYDUS LIFESCIENCES LTD21,483.54.4495,280.3
DIVIS LABORATORIES LTD8,614.018.17156,524.0
MANKIND PHARMA LTD11,018.09.34102,890.0
TORRENT PHARMACEUTICALS LTD11,225.09.33104,742.0
LUPIN LTD21,431.34.3492,929.7
AUROBINDO PHARMA LTD30,295.02.3972,478.2
ABBOTT INDIA LTD6,066.19.5357,784.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.39x
Max industry PS 18.17x
Median industry PS 5.03x
Average industry PS 7.17x



You may also like the below Video Courses